Experimental estimate · v0.11

Peru dengue outbreak

Peru2024 · weeks 1–23

Report prepared 8 October 2026

Estimated USU1.9 million

Acute illness, including fatal cases

Reported deaths207

Source discrepancy: summary says 203. Source context

Cases modeled249,843

reported cases

1 USU is the modeled burden of one specified six-hour kidney-stone pain reference. It is a common reporting unit, not a claim that the experiences feel the same.

Approximate, assumption-based USU for the included experience. Deaths are a separate measure. Includes fatal illness.

What this estimate tells us

About 1.91 million USU is assigned to 249,843 reported cases in this snapshot. The estimate combines an ordinary acute course for 249,636 other reported cases with a complete fatal illness course for 207 reported deaths. All dengue entries use the same two courses. Source coverage and the number of cases in each group still differ.

From one modeled experience to the total

Cases in the reported total
249,843
Modeled average per case
≈ 7.6 USU
Estimated total
≈ 1.9 million USU

Population count × modeled average ≈ total USU

This is a modeled average across the included cases. Other reported cases are assigned about 7.6 USU each; reported fatal cases are assigned about 17.8 USU each. Each course is weighted by its case count. The average can differ between outbreaks because the reported mix of cases differs, even when the same course assumptions are used. See the two courses and their assumed durations →

This is an assumption-based average, not an observed average or a prediction for any individual. Figures shown here are rounded; calculations use unrounded values. How to read these averages.

Fatal-case duration comes from historical studies in other settings, not measurements in this outbreak. The average intensity is an author-selected assumption. Clinical severity and conscious time are not reconstructed; persistent symptoms remain unestimated.

Two groups, one course per case

249,843 reported cases = 249,636 other reported cases + 207 reported fatal cases. “Other” includes unresolved outcomes and does not mean known survivors or mild cases.

Other reported cases

249,636 cases

5 days × average intensity 3

249,636 × 5 × 24 × 3 ÷ 47.25

≈ 7.6 USU per case

Estimated total for this group: about 1.9 million USU.

Reported fatal cases

207 cases

7 days × average intensity 5

207 × 7 × 24 × 5 ÷ 47.25

≈ 17.8 USU per case

Estimated total for this group: about 3.7 thousand USU.

Combined estimateAbout 1.91 million USU

Rounded for readability. The downloadable inputs retain the calculation precision.

The fatal course replaces the ordinary allowance for those same cases. It covers the complete illness ending at death, so there is no additional terminal-period charge. Death itself, lost life years and bereavement are not assigned USU.

All dengue reports use these same two courses. Differences come from the reported case and death counts and their coverage, not country-specific intensity judgments.

Intensity is a combined 0–10 average over the elapsed course, including relief, sleep and intervals without experience. No intensity is assigned after death or to known absence of experience. Why divide by 47.25?

Why these durations and intensities?

Dengue: other reported cases

The existing five-day acute course is retained for cases not reported dead at the snapshot cutoff. WHO gives a 2-7-day symptom window. Five days is a representative choice, not a measured mean or a survivor-specific estimate. Other cases include unresolved outcomes and severe cases not reported dead; no future deaths are imputed. Later fatigue is excluded. [S2]

Fever, headache, body/joint aches and nausea support a meaningful acute symptom burden. Assigned intensity 3 is a working average across the whole day, including relief and sleep. It is lower than a severe-pain peak. WHO does not establish the value 3 or its ratio to the reference. [S2]

Dengue: fatal illness

Seven days is a provisional representative course from symptom onset to death. A Puerto Rico series of 58 fatal laboratory-positive cases reported a median of 7.1 days; in a Malaysian review of 322 deaths, 66.5% occurred on illness days 4-7. A Singapore series of 28 adults reported a longer median of 12 days. These differing populations support testing alternatives. Seven days is our choice, not a pooled mean or an observed average for the listed outbreaks. [S18] [S19] [S20]

We assign intensity 5 as one combined average for pain and other experienced distress throughout the fatal illness. Clinical descriptions of abdominal pain, vomiting and breathing difficulty motivate testing a higher average than the ordinary value 3. The exact value 5 and its ratio to 3 are judgments, not measured USU conversions. This elapsed-time average allows for earlier milder illness, treatment, relief, sleep and periods without experience; it is not a constant severe-pain score. [S17]

What changed in version 0.5?

Version 0.4 assigned the same 5-day, intensity-3 course to all 249,843 cases: 1,903,565.71 USU. The revised estimate is 1,905,668.57 USU, a change of +2,102.86 USU (+0.110%).

For the 207 reported fatal cases, 1,577.14 USU is removed and replaced with 3,680.00 USU. The reference unit and source counts are unchanged.

What changes the estimate?

Under the central assumptions, other reported cases contribute 99.8%; reported fatal cases contribute 0.2% of the total. Both courses are varied below.

Each row uses the same reported counts and included experiences. The lower and higher rows change duration and intensity together for every included course.

Illustrative scenarios for the whole estimate
ScenarioAssumed coursesEstimated USU
Lower assumptionsOther reported cases: 2 days at intensity 2
Reported fatal cases: 5 days at intensity 4
509 thousand
Central assumptionsOther reported cases: 5 days at intensity 3
Reported fatal cases: 7 days at intensity 5
1.91 million
Higher assumptionsOther reported cases: 7 days at intensity 4
Reported fatal cases: 12 days at intensity 6
3.56 million

These are alternative assumptions, not confidence intervals or bounds. Counts can be incomplete or misclassified; omitted experiences and the validity of the intensity scale remain outside this calculation. Actual burden could fall outside these examples.

Change one assumption at a time

Only the named input changes. Every other duration, intensity and count stays at its central value. Each result is the total for the whole report.

Effect of individual inputs
Input variedLower input and resulting totalHigher input and resulting total
Other reported cases
Duration
2 days
764 thousand USU
7 days
2.67 million USU
Other reported cases
Average intensity
2 / 10
1.27 million USU
4 / 10
2.54 million USU
Reported fatal cases
Duration
5 days
1.90 million USU
12 days
1.91 million USU
Reported fatal cases
Average intensity
4 / 10
1.90 million USU
6 / 10
1.91 million USU

Fatal illness remains a replacement course for the same reported fatal cases; no case is counted twice. How the scenarios are chosen.

Download scenario calculations (CSV) · Reproduce the scenarios (Python)

What goes into this number?

Included

One complete acute illness course per reported case, combining pain and other acute distress. The 207 cases reported dead receive a seven-day, intensity-5 fatal course; the other 249,636 cases retain the five-day, intensity-3 assumption. Other cases include unresolved outcomes and severe cases not reported dead. They are not all known survivors or mild cases.

Source population and period

PAHO/WHO, 18 June 2024, p. 4: 249,843 reported cases through EW 23. The Andean series is described as suspected cases. No correction for missed or misclassified cases is applied. [S1]

Outside this estimate

Later fatigue, prolonged recovery, a separate severity adjustment for other reported cases, caregiver distress, bereavement, unreported infections, death itself and lost life years.

Omitted experiences are unestimated, not known to be zero. This is not a complete event total or a guaranteed lower bound.

Whole representative courses are assigned to the source-defined cases or cohort. Course time can extend beyond the reporting dates. The fatal course ends at death; individual symptom histories and timing are not reconstructed. Other cases include unresolved outcomes, and no future deaths are imputed. No causal baseline or suffering after death is assigned.

Mortality source context

207 reported fatal cases are used within the 249,843-case population to select a complete fatal illness course. Those cases are removed from the ordinary group, and the death count remains separately visible. The country detail uses 207 deaths; the same source summary uses 203. The main calculation retains 207, and the report shows the effect of the alternative figure. [S1]

Suffering before death: included

A complete fatal illness course is included for 207 source-defined fatal cases. It replaces their ordinary allowance; each case receives one course. This does not cover every possible death or consequence.

See the two-group calculation →

Why this death count fits the calculation: PAHO country detail on page 4 reports 249,843 cases and 207 fatal cases through EW 23 of 2024. Its 0.083% case-fatality rate matches 207 divided by 249,843. We retain this country detail over the conflicting summary figure of 203. [S1]

What if we use the alternative death figure?

PAHO summary on page 1, contrasted with country detail on page 4. [S1]

Keeping the case count and both courses fixed, using 203 deaths gives 1,905,627.94 USU, compared with 1,905,668.57 USU using 207. The difference is -40.63 USU. The main estimate retains the country-detail figure and its matching case-fatality rate; the discrepancy remains unresolved.

USU estimates experienced suffering during lived time. Death itself and lost life years are not assigned USU. A report can use a death count to identify a distinct course of suffering before death, as in the disease fatal-course calculations. Bereavement remains unestimated.

Sources and calculation data

Related reading

The shared fatal dengue course

Understanding the underlying data

Understanding suspected, confirmed and severe dengue counts →

This guide explains the measures; its places and reporting period differ from this estimate.

Search WSI